Management of Hyperglycemia in Lactating Mothers

Insulin Therapy During Lactation

The American Diabetes Association recommends insulin as the preferred pharmacologic agent for managing hyperglycemia during breastfeeding, as it does not cross into breast milk in measurable amounts and poses no risk to the infant 1
Breastfeeding substantially lowers blood glucose levels, requiring insulin-treated women to consume a carbohydrate-containing snack before or during nursing sessions to prevent hypoglycemia, with a significant decrease in total daily basal insulin requirements during lactation, approximately 34% lower than prepregnancy doses 2, 3, 4

The American College of Obstetricians and Gynecologists suggests metformin is generally considered safe during breastfeeding, though it is excreted into breast milk, with limited data suggesting no harmful neonatal effects, but larger safety studies are still needed 1
Glyburide and glipizide can be safely used by breastfeeding women, as second-generation sulfonylureas are generally preferred over first-generation agents during lactation 1
Acarbose and thiazolidinediones lack sufficient safety data for breastfeeding and should be avoided until more evidence is available 1

The Academy of Nutrition and Dietetics recommends energy requirements during the first 6 months of lactation require an additional 200 calories above the pregnancy meal plan, with a minimum intake of 1,800 kcal/day to meet nutritional requirements for lactation while allowing slow weight loss of 1-2 lb/month 2, 3
Adequate energy intake with appropriate meal and snack distribution is essential to prevent ketosis during lactation, and overweight women may safely lose up to 2 kg/month without affecting milk volume 2, 3

The American Association of Clinical Endocrinologists recommends self-monitoring of blood glucose should include fasting glucose upon waking and postprandial measurements after each main meal, with particular attention to timing around breastfeeding sessions, and target glucose levels of fasting <95 mg/dL, 1-hour postprandial <140 mg/dL, and 2-hour postprandial <120 mg/dL 5

The Endocrine Society advises against assuming prepregnancy insulin doses are appropriate immediately postpartum, as insulin sensitivity increases dramatically with placenta delivery, and using prepregnancy doses will cause severe hypoglycemia 4
The American Academy of Pediatrics recommends ensuring adequate bedtime snacks and considering setting alarms for glucose checks during extended nursing sessions to avoid overlooking the increased hypoglycemia risk during nighttime feedings 2, 3

The American College of Obstetricians and Gynecologists suggests women with a history of gestational diabetes who require ongoing diabetes management during lactation should undergo testing for persistent diabetes or prediabetes at 4-12 weeks postpartum using a 75-g oral glucose tolerance test, as they have a 50-70% risk of developing type 2 diabetes over 15-25 years 4, 5